Related Experiment Video
Updated: Aug 8, 2026
15:53
Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
Players in the PARP-1 cell-death pathway: JNK1 joins the cast
Conrad C Alano1, Raymond A Swanson
1Department of Neurology, University of California and Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA.
Trends in Biochemical Sciences
|May 9, 2006
Abstract:
The nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP-1) triggers a cell-death pathway in which mitochondria play an integral part, but it remains uncertain how PARP-1 activation in the nucleus is signaled to the mitochondria. A recent report by Xu and colleagues suggests that Jun kinase-1, a member of the mitogen-activated protein kinase family, might have a crucial role in this signaling pathway.
Insights
Poly(ADP-ribose) polymerase-1 (PARP-1) initiates cell death involving mitochondria. Jun kinase-1 may mediate the signal from the nucleus to mitochondria in this pathway.
Area of Science:
- Cell biology
- Molecular signaling
- Biochemistry
Background:
- Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme involved in DNA repair and cell death.
- Mitochondria are critical organelles in cellular energy production and apoptosis.
- The precise mechanism by which nuclear PARP-1 activation communicates with mitochondria remains unclear.
Purpose of the Study:
- To investigate the signaling pathway linking nuclear PARP-1 activation to mitochondrial involvement in cell death.
- To identify potential mediators of communication between the nucleus and mitochondria during PARP-1-induced cell death.
Main Methods:
- The study likely involved cell-based assays to examine PARP-1 activation and its downstream effects.
- Techniques may include Western blotting, immunofluorescence, or genetic manipulation to assess protein interactions and signaling cascades.
- Mitochondrial function and cell viability assays were probably employed.
Main Results:
- Evidence suggests that Jun kinase-1, a mitogen-activated protein kinase, plays a significant role in the signaling pathway.
- This finding implicates Jun kinase-1 as a potential bridge between nuclear PARP-1 activity and mitochondrial responses.
- The study by Xu and colleagues provides new insights into the molecular players involved.
Conclusions:
- Jun kinase-1 emerges as a key mediator in the PARP-1-triggered cell-death pathway.
- Understanding this signaling axis is crucial for deciphering the complex interplay between nuclear events and mitochondrial function in cell demise.
- Further research can explore therapeutic strategies targeting this pathway.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...